Three separate research teams have shown that incorporating pharmacists into outpatient diabetes clinics can significantly improve key markers of disease progression, including a nearly five-point mean reduction in hemoglobin A1c (HbA1c; glycosylated hemoglobin).
The results, presented at the ASHP Midyear Clinical Meeting in 2020 and the ASHP Summer Meetings in 2022, were achieved using both telehealth and in-person sessions with patients.
The results are also part of a larger